• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Packaging Technology

    Elemental Impurities: The Time Has Come

    Continuous vs. Batch Production

    2018: The evolution of pharmaceutical packaging

    Formulation Development Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    InClinica Names BD Manager

    SCHOTT Introduces syriQ BioPure

    Heritage Pharma Makes Leadership Changes

    JLL and Water Street Acquire Triplefin

    WuXi AppTec Opens Laboratory Testing Facility in NJ
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    WuXi AppTec Opens Laboratory Testing Facility in NJ

    Arcinova Receives £1.5M Innovate UK Grant

    Vetter Welcomes Illinois Governor

    Sterling Pharma Invests £6M To Expand Offerings

    PhoenixMD, STA Enter Manufacturing Agreement
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    INTERPHEX: Adents Showcases Cloud-Based Serialization Solution

    Almac Group Expands Packaging Capabilities

    Catalent Bolsters Clinical Supply Capabilities

    West, Stevanato Group Enter Ompi EZ-fill Alliance

    Pharmaceutical Packaging Technology
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    WuXi AppTec Opens Laboratory Testing Facility in NJ

    ICON, Intel Enter Pharma Analytics Platform Pact

    AMRI Renews NIH Contract

    Sterling Pharma Invests £6M To Expand Offerings

    PhoenixMD, STA Enter Manufacturing Agreement
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Blockchain: The Next Big Trend in BioPharma?

    Emergent Completes Market Authorization

    Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle: ICH Q12

    LSNE Expands Capabilities and QC Laboratory Space

    Evotec Launches Drug Development Service
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Pfizer CentreOne Contract Manufacturing

    iuvo BioScience

    Rockledge Pharmaceutical Manufacturing, LLC

    IQVIA

    Almac Group
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Teva, Lonza Enter Biosimilars JV

    Related CONTENT
    • Growth of Biosimilars: Implications for Safety and Risk Management
    • 2015 in Review: 6 Key Trends Affecting CMOs
    • Injectables: The New Oral?
    • Biosimilars Outsourcing and Capacity
    • Stellar Biotech and Neovacs Form JV
    01.20.09
    Teva Pharmaceutical Industries and Lonza will establish a joint venture to develop, manufacture and market a portfolio of biosimilars. The joint venture is expected to begin activities during 1Q09, subject any applicable regulatory approvals. Financial details of this agreement were not disclosed.

    "We had identified biosimilars as a major growth driver for Teva in our long-term strategy and have been augmenting our knowledge base, capabilities and infrastructure to position Teva as a leader in this market," said Shlomo Yanai, Teva's president and chief executive officer. “This strategic partnership bolsters our biologics capabilities. Lonza is an ideal partner for Teva in this field with its deep knowledge and experience in biopharmaceutical development, large-scale manufacturing and state-of-the-art manufacturing facilities. Combined with Teva’s global leadership and expertise in clinical development and marketing of generic pharmaceuticals, the joint venture generates significant opportunities and benefits for both companies.”

    “We are excited to enter into this joint venture. The field of biosimilars is a natural extension of Lonza’s existing life-sciences portfolio, and represents the next strategic step for the company. With Teva we have found the right strategic partner to develop this new activity, which will deliver new opportunities for both companies," commented Stefan Borgas, Lonza’s chief executive officer. “We are confident that our capabilities in the area of biologics manufacturing will add value to this joint venture; while at the same time, the agreement ensures that we will be able to continue to fully support the development of new technology and business of our existing innovator customers.”

    Teva and Lonza retain the ability to explore additional opportunities in the area of biosimilars beyond this partnership.

    Related Searches
    • Biosimilars
    Suggested For You
    CMOs & Biosimilars Mfg. in the U.S. CMOs & Biosimilars Mfg. in the U.S.
    Uhlmann Joins Open-SCS Group Uhlmann Joins Open-SCS Group
    Sanofi and Lonza in $285mn Biologics Pact Sanofi and Lonza in $285mn Biologics Pact
    Beximco Pharma Forms JV with BioCare Manufacturing Beximco Pharma Forms JV with BioCare Manufacturing
    Teva Appoints Chief Legal Officer Teva Appoints Chief Legal Officer
    Teva, Celltrion Enter Biosimilar Partnership Teva, Celltrion Enter Biosimilar Partnership
    Bayer, CRISPR Name JV Bayer, CRISPR Name JV
    Mayne Pharma Completes $652M Teva/Allergan Generic Acquisition   Mayne Pharma Completes $652M Teva/Allergan Generic Acquisition
    The Top 25 Report The Top 25 Report
    19 Bayer 19 Bayer
    Stellar Biotech and Neovacs Form JV Stellar Biotech and Neovacs Form JV
    Biosimilars Outsourcing and Capacity Biosimilars Outsourcing and Capacity
    Injectables: The New Oral? Injectables: The New Oral?
    2015 in Review: 6 Key Trends Affecting CMOs 2015 in Review: 6 Key Trends Affecting CMOs
    Growth of Biosimilars: Implications for Safety and Risk Management Growth of Biosimilars: Implications for Safety and Risk Management

    Related Breaking News

    • Bio News | Breaking News | Industry News
      BioPlan Associates

      BioPlan Associates' 15th Annual Bio Mfg. Study is Open

      Participate and get a FREE aggregated summary of this year's results
      02.16.18

    • Bio News | Breaking News | Collaborations & Alliances
      Sandoz & Biocon Enter Global Partnership

      Sandoz & Biocon Enter Global Partnership

      To develop and commercialize biosimilars in immunology and oncology
      01.23.18

    • Trials & Filings
      Amgen, Allergan MVASI Biosimilar Wins EC Approval

      Amgen, Allergan MVASI Biosimilar Wins EC Approval

      Becomes first biosimilar bevacizumab approved by the EC for the treatment of certain types of cancers
      01.19.18


    • Aseptic Processing | Bio News | Breaking News | Facilities | Fill/Finish | Industry News
      New Aseptic Fill/Finish CMO Launches Operations

      New Aseptic Fill/Finish CMO Launches Operations

      Wuxi Griffin is a new contract manufacturer in China with Western management style and quality standards.
      01.16.18

    • Bio News | Breaking News | Collaborations & Alliances | Industry News | Trials & Filings
      Biocon and Mylan Receive ANVISA Approval

      Biocon and Mylan Receive ANVISA Approval

      For the first biosimilar Trastuzumab to be approved in Brazil
      01.02.18

    • Bio News | Industry News
      Teva Launches Generic Version of Reyataz

      Teva Launches Generic Version of Reyataz

      The drug is for the treatment of HIV-1
      12.29.17


    • Bio News | Breaking News | Industry News | Trials & Filings
      Clover Receives CTA Approval For Enbrel Biosimilar

      Clover Receives CTA Approval For Enbrel Biosimilar

      The CFDA's approval is for SCB-808, for the treatment of rheumatoid arthritis
      12.29.17

    • Bio News | Collaborations & Alliances | Industry News
      Selexis SA and Turgut Pharmaceuticals Expand Agreement

      Selexis SA and Turgut Pharmaceuticals Expand Agreement

      The expanded partnership adds onto the two existing commercial license agreements between the companies
      12.20.17

    • Bio News | Breaking News | Industry News
      FDA Approves Sanofi

      FDA Approves Sanofi's Admelog

      This is the first follow-on mealtime insulin ever approved by the FDA
      12.12.17


    • Trials & Filings
      Sandoz Phase I Biosimilar Achieves Positive Results

      Sandoz Phase I Biosimilar Achieves Positive Results

      Proposed biosimilar to Neulasta demonstrates PK, PD, safety and efficacy
      12.08.17

    • Bio News | Breaking News | Facilities | Industry News
      BIOCAD Launches New Mfg. Site in North Africa

      BIOCAD Launches New Mfg. Site in North Africa

      Russian company will make biosimilars of rituximab and bevacizumab for cancer
      12.01.17

    • Bio News | Breaking News | Facilities | Industry News
      Lonza Pharma & Biotech Launches Ibex Solutions

      Lonza Pharma & Biotech Launches Ibex Solutions

      Represents an innovative new concept in biological manufacturing and development
      07.31.17

    • Bio News | Breaking News | cGMP Manufacture | Facilities | Industry News
      Axis Biotec, PlantForm Enter Bio Mfg. Pact

      Axis Biotec, PlantForm Enter Bio Mfg. Pact

      Plans call for construction of an innovative tobacco-based biopharma expression and pilot manufacturing facility in Brazil
      06.26.17

    • Bio News | Breaking News | Facilities | Industry News
      Sartorius Stedim Biotech Launches Chemistry Testing Services

      Sartorius Stedim Biotech Launches Chemistry Testing Services

      To be offered by subsidiary BioOutsource
      05.05.17

    • Samsung Bioepis Obtains First Drug Approval in the U.S.

      Samsung Bioepis Obtains First Drug Approval in the U.S.

      FDA approves biosimilar Renflexis across all eligible indications
      04.24.17

    Breaking News
    • InClinica Names BD Manager
    • SCHOTT Introduces syriQ BioPure
    • Heritage Pharma Makes Leadership Changes
    • JLL and Water Street Acquire Triplefin
    • WuXi AppTec Opens Laboratory Testing Facility in NJ
    View Breaking News >
    CURRENT ISSUE

    April 2018

    • Pharmaceutical Packaging Technology
    • Elemental Impurities: The Time Has Come
    • Continuous vs. Batch Production
    • 2018: The evolution of pharmaceutical packaging
    • Formulation Development Trends
    • Changing Dynamics: The CDMO market in focus
    • Contract BioManufacturing in China: Creating a New Segment
    • View More >

    Copyright © 2018 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.